Abbott Laboratories

Abbott Laboratories

97.18
EUR
-0.88
(-0.90%)
151.68BMarket Cap
Jan 27Next Earn

Total Valuation

EUR

As of September 30, 2026, Abbott Laboratories carries a market capitalization of 151.68B, placing it among publicly traded companies globally. Its enterprise value stands at 175.91B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap151.68B
Enterprise Value175.91B

Important Dates

Abbott Laboratories's next confirmed earnings release is scheduled for January 27, 2027.

Earnings Date1/27/2027

Share Statistics

As of September 30, 2026, Abbott Laboratories has 1.73B shares outstanding.

Shares Outstanding1.73B

Valuation Ratios

These figures are as of September 30, 2026.

PB Ratio3.37
P/TBV Ratio-142.43

Financial Position

As of September 30, 2026, Abbott Laboratories maintains a current ratio of 1.45, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Current Ratio1.45
Quick Ratio1.00
Debt / Equity60.36

Financial Efficiency

These figures cover the twelve months ended September 30, 2026.

Employee Count115,000.00

Taxes

EUR

Over the twelve months ended September 30, 2026, Abbott Laboratories recorded 1.12B in income tax expense.

Income Tax1.12B

Stock Price Statistics

EUR

As of the close on November 17, 2026, Abbott Laboratories's stock has declined approximately 14.15% over the past 52 weeks. The 50-day moving average sits at 92.00, while the 200-day moving average is 87.84.

52-Week Price Change-14.15%
50-Day Moving Average92.00
200-Day Moving Average87.84

Balance Sheet

EUR

As of September 30, 2026, Abbott Laboratories holds 3.79B in cash and equivalents against 27.49B in total debt, resulting in a net debt position of 23.92B. Total book value stands at 45.02B, with working capital of 6.48B providing operational flexibility.

Cash & Cash Equivalents3.79B
Total Debt27.49B
Net Debt23.92B
Equity (Book Value)45.02B
Book Value Per Share25.99
Working Capital6.48B

Cash Flow

EUR

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-1.41B

Dividends & Yields

EUR

Over the twelve months ended September 30, 2026, Abbott Laboratories paid dividends of 1.64 per share.

Dividend Per Share1.64

Stock Splits

Abbott Laboratories's most recent stock split took place on June 1, 1998 with a 1:2 split ratio.

Last Split Date6/1/1998
Split Ratio1:2